Literature DB >> 7428807

Macrophage handling of soluble immune complexes. Use of specific inhibitors to study the biochemical events involved in complex catabolism.

R G Leslie.   

Abstract

Events involved in the macrophage catabolism of soluble immune complexes have been investigated using quantitative assays of complex ingestion and digestion, and specific disruptors of microtubule and microfilament organization (colchicine and cytochalasin B) a local anesthetic (Lidocaine), and two serine esterase inhibitors (TLCK and TPCK) of which one (TPCK) is a reported inhibitor of phagocytosis (Nagai, K. et al., FEBS Lett. 1978. 92:299). Marked selective inhibition of ingestion, pinosome-lysosome fusion and complex degradation was observed in the presence of cytochalasin B, Lidocaine and TLCK, respectively. The biochemical basis of the selective action of these inhibitors is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428807     DOI: 10.1002/eji.1830101015

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  The ingestion and degradation of soluble immune complexes by guinea-pig macrophages and neutrophils.

Authors:  R G Leslie; K Coupland
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Measurement of the rates of basal pinocytosis of horseradish peroxidase and internalization of heat-aggregated IgG by macrophages from normal and streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

3.  Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis.

Authors:  James M Turman; Alana M Cheplowitz; Charu Tiwari; Thushara Thomas; Dhruvi Joshi; Menakshi Bhat; Qian Wu; Erik Pong; Seung Y Chu; David E Szymkowski; Amit Sharma; Stephanie Seveau; John M Robinson; Jesse J Kwiek; Dennis Burton; Murugesan V S Rajaram; Jonghan Kim; Lars Hangartner; Latha P Ganesan
Journal:  J Immunol       Date:  2021-02-10       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.